The beneficial effects of CD200 were demonstrated in prior animal studies which found that the CD200/CD200R pathway lowered levels of inflammation and disease susceptibility in different autoimmune disease models, including those of arthritis and multiple sclerosis (89). Here, CD200 is linked to multiple sclerosis.